April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreMarch 17, 2026
According to market projections, the DNA damaging agents sector is expected to grow from USD 17.12 billion in 2025 to USD 51.63 billion by 2035, reflecting a CAGR of 11.67%. Ongoing developments in the cancer domain are impacting the global market expansion. North America led the market due to a rise in cancer cases....
March 16, 2026
Market insights predict, the veterinary hematology analyzers industry is expected to grow from USD 1.06 billion in 2025 to USD 1.81 billion by 2035, driven by a CAGR of 5.44%. The veterinary hematology analyzers market is expanding due to growing animal health monitoring as well as increasing use of portable analyzers. North America led the market ...
March 16, 2026
Projections indicate that, infectious diseases industry is projected to rise from USD 23 billion in 2025 to USD 40.42 billion by 2035, reflecting a CAGR of 5.8% over the next decade. The continuous emergence of various pathogens, resulting in persistent diseases, rapid diagnostics, and point-of-care testing, is the major driving force behind the di...
March 16, 2026
Gene Therapy Clinical Trials Market ( By Therapy Modality: In vivo Gene Therapy, Ex vivo Gene-modified Cell Therapy; By Vector/Delivery Platform: AAV, Lentiviral Vectors, Adenoviral/Oncolytic & Others, Non-viral, Genome Editing; By Therapeutic Area: Oncology, Rare/Genetic & Metabolic Disorders, Ophthalmology, Hematology, Neurology/CNS, Card...
March 16, 2026
According to market projections, the global allergy diagnostics market, valued at USD 6.42 billion in 2025, is anticipated to reach USD 18.18 billion by 2035, growing at a CAGR of 10.96% over the next decade. The rising incidence of allergies and technological advancements bolster market growth. North America dominated the global market due to the ...
March 16, 2026
According to market projections, the global analgesics market, valued at USD 46.53 billion in 2025, is anticipated to reach USD 85.24 billion by 2035, growing at a CAGR of 6.24% over the next decade. The rising prevalence of chronic pain and the availability of OTC drugs bolster market growth. North America dominated the global market due to the pr...
March 16, 2026
Projections indicate that, the global antibody discovery market will increase from USD 9.1 billion in 2025 to USD 22.64 billion by 2035, experiencing a CAGR of 9.54% over the next 10 years. Rising prevalence of chronic and infectious diseases has estimated to drive the growth of the market. North America led the global market owing to the presence ...
March 16, 2026
Based on our market forecasts, the U.S. AI-Driven diabetic retinopathy screening market was valued at USD 191.05 million in 2025 and is expected to grow from USD 231.59 million in 2026 to around USD 1308.85 million by 2035, expanding at a CAGR of 21.22% during 2026–2035....
March 13, 2026
Market insights predict, the orthopedic devices industry is expected to grow from USD 65.8 billion in 2025 to USD 100.63 billion by 2035, driven by a CAGR of 4.34%. The rising prevalence of orthopedic disorders and advancements in medical devices are the major growth factors of the market. Favorable regulatory policies and increasing investments le...
March 13, 2026
Market insights predict the global life science reagents industry will increase from USD 65.95 billion in 2025 to USD 115.24 billion by 2035, achieving a CAGR of 5.74%. The life science reagents market is growing due to rising demand for personalized medicine. North America is leading due to the focus on developing biologics....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
